Free Trial
NASDAQ:GHSI

Guardion Health Sciences (GHSI) Stock Price, News & Analysis

$9.57
-0.28 (-2.84%)
(As of 07/26/2024 ET)
Today's Range
$9.50
$9.90
50-Day Range
$7.90
$10.10
52-Week Range
$5.01
$10.75
Volume
1,077 shs
Average Volume
2,605 shs
Market Capitalization
$12.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GHSI stock logo

About Guardion Health Sciences Stock (NASDAQ:GHSI)

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

GHSI Stock Price History

GHSI Stock News Headlines

Amazon coin set to soar 25X – starting August 19th
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…
Guardion Health Sciences Announces
Amazon coin set to soar 25X – starting August 19th
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…
Guardion Health Sciences Inc GHSI
Guardion Health Sciences, Inc. (GHSI)
Guardion Health Swings To Annual Net Profit, Revenue Improves
See More Headlines
Receive GHSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2024
Today
7/26/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GHSI
Employees
10
Year Founded
2009

Profitability

Net Income
$160,000.00
Pretax Margin
-16.69%

Debt

Sales & Book Value

Annual Sales
$12.25 million
Cash Flow
$0.14 per share
Book Value
$6.39 per share

Miscellaneous

Free Float
1,267,000
Market Cap
$12.25 million
Optionable
Not Optionable
Beta
0.91

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Robert Neal Weingarten (Age 72)
    Independent Chairman & Secretary
    Comp: $110k
  • Ms. Janet Hall (Age 65)
    President & CEO
    Comp: $704.85k
  • Ms. Katie Cox (Age 54)
    Chief Accounting Officer
    Comp: $275k
  • Mr. Craig J. Sheehan (Age 53)
    Chief Commercial Officer
    Comp: $457.5k

GHSI Stock Analysis - Frequently Asked Questions

How have GHSI shares performed this year?

Guardion Health Sciences' stock was trading at $5.34 at the beginning of 2024. Since then, GHSI shares have increased by 79.2% and is now trading at $9.57.
View the best growth stocks for 2024 here
.

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences, Inc. (NASDAQ:GHSI) released its quarterly earnings data on Monday, May, 13th. The company reported ($3.71) EPS for the quarter. The business earned $3 million during the quarter. Guardion Health Sciences had a negative trailing twelve-month return on equity of 77.29% and a negative net margin of 16.69%.

When did Guardion Health Sciences' stock split?

Shares of Guardion Health Sciences reverse split on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

When did Guardion Health Sciences IPO?

Guardion Health Sciences (GHSI) raised $6 million in an initial public offering (IPO) on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

How do I buy shares of Guardion Health Sciences?

Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO) and Ocugen (OCGN).

This page (NASDAQ:GHSI) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners